EMPIRE GENOMICS

WIPO WIPO 2023

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark EMPIRE GENOMICS was filed as Word mark on 06/19/2023 at the World Intellectual Property Organization.

Trademark Details Last update: August 11, 2023

Trademark form Word mark
File reference 1742629
Countries Australia Brazil Canada Switzerland European Community United Kingdom Israel Iceland Japan South Korea Norway New Zealand Singapore
Base trademark US No. 97759557, January 18, 2023
Application date June 19, 2023
Expiration date June 19, 2033

Trademark owner

60 Berry Dr.
Pacheco CA 94553
US

Trademark representatives

601 W. Riverside Ave., Suite 1400 Spokane WA 99201 US

goods and services

01 Chemicals, namely, buffers for hybridization; diagnostic preparations for scientific or research use; diagnostic kits composed of DNA probes, reagents and antibodies for scientific research; biochemicals for use in scientific and medical research, namely, engineered and natural cytokinses, growth factors, proteins, hormones, enzymes, receptors, toxins, antigens and antibodies for the regulation of human, animal, plant, viral, and microbial genes for use in scientific and medical research; assays for research purposes; biochemical preparations for scientific purposes; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; biochemical reagents used for non-medical purposes; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; chemical preparations, namely, silica based density centrifugation media, to be used in biochemical and clinical research; chemical test kits for extracting DNA and RNA for laboratory or research use; enzymes for use in protein hydrolysis; protein arrays and nucleotide arrays for scientific and medical research; protein in raw material form for scientific and medical research; testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use
05 Diagnostic kits composed of DNA probes, reagents and antibodies for clinical medical laboratory use; biochemical nucleic acid reagent probes for medical diagnostic use; reagents for detecting cancer for medical diagnostic use; cancer diagnostic kit comprised of medical diagnostic reagents and assays

Trademark history

Date Document number Area Entry
June 19, 2023 2023/28 Gaz US Registration

ID: 141742629